Trial Condition(s):

Neoplasms

Effect of neomycin on the pharmacokinetics of regorafenib

Bayer Identifier:

16675

ClinicalTrials.gov Identifier:

NCT02001909

EudraCT Number:

2013-001721-18

Study Completed

Trial Purpose

To investigate the effect of neomycin on the pharmacokinetics (PK) of regorafenib in healthy male subjects

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
27
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Stivarga (Regorafenib, BAY73-4506)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Berlin, Germany, 13353

Status
Completed
 

Trial Design